Rothman KJ, Suissa S. Exclusion of immortal person-time. Pharmacoepidemiol Drug Saf. 2008 Oct 1;17(10):1036.
Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Arana A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Pharmacoepidemiol Drug Saf. 2008 Oct 1;17(10):1037. doi: 10.1002/pds.1636
Danese MD, Belozeroff V, Smirnakis K, Rothman KJ. Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol. 2008 Sep 1;3(5):1423-9.
Solomon DH, Glynn RJ, Rothman KJ, Schneeweiss S, Setoguchi S, Mogun H, Avorn J, Sturmer T. Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis Care Res (Hoboken). 2008 Aug 15;59(8):1097-104.
Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes. 2008 Aug 1;32 Suppl 3:S56-9.
Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Rothman KJ, Fischer M, Mehta J, Winkelmayer WC. The effect of altitude on dosing and response to erythropoietin in ESRD. J Am Soc Nephrol. 2008 Jul 1;19(7):1389-95.
Bradbury BD, Wang O, Critchlow CW, Rothman KJ, Heagerty P, Keen M, Acquavella JF. Relative mortality and epoetin alfa dose in hemodialysis patients - Reply. Am J Kidney Dis. 2008 May 1;51(5):865-6.
Pedersen L, Norgaard M, Rothman KJ, Sorensen HT. Loratadine during pregnancy and hypospadias. Epidemiology. 2008 Mar 1;19(2):359-60.
Stuermer T, Rothman KJ, Avorn J. Pharmacoepidemiology and "in silico" drug evaluation: is there common ground? J Clin Epidemiol. 2008 Mar 1;61(3):205-6.
Hutchison GB, Rothman KJ, Cole P, Mack T, Weiss NS, Monson RR. Remembrance. Brian MacMahon, 1923-2007. Epidemiology. 2008 Mar;19(2):357.
Hutchison GB, Rothman KJ, Cole P, Mach T, Weiss NS, Monson RR. Brian MacMahon, 1923-2007. Epidemiology. 2008 Mar 1;19(2):357.
Rothman KJ, Greenland S, Lash TL. Case-control studies. In: Everitt B, Melnick E, editors. Encyclopedia of quantitative risk analysis and assessment. New York: United States. Wiley; 2008.
Bradbury BD, Wang O, Critchlow CW, Rothman KJ, Heagerty P, Keen M, Acquavella JF. Exploring relative mortality and epoetin alfa dose among hemodialysis patients. Am J Kidney Dis. 2008 Jan 1;51(1):62-70.
Poole C, Rothman KJ, Dreyer NA. Leukemia near Pilgrim nuclear-power plant, Massachusetts. Lancet. 1988 Dec 3;332(8623):1308. doi: 10.1016/S0140-6736(88)92915-7
Rothman KJ, Poole C. A strengthening programme for weak associations. Int J Epidemiol. 1988 Dec 1;17(4):955-9.
Zierler S, Theodore M, Cohen A, Rothman KJ. Chemical quality of maternal drinking water and congenital heart disease. Int J Epidemiol. 1988 Sep;17(3):589-94.
Rothman KJ. Foreword. In: Hartzema AG, Porta MS, Tilson HH, editors. Pharmacoepidemiology: an introduction. Cincinnati: OH. Harvey Whitney Books; 1988.
Cann CI, Rothman KJ. Epidemiology of laryngeal cancer. In: Fried MP, editors. The larynx. Boston: MA. Little, Brown and Co; 1988.
Dreyer NA, Loughlin JE, Lanes SF, Rothman KJ. Mortality among employees of a nuclear power company. J Occup Environ Med. 1988 Jan 1;30(12):988-9.
Zierler S, Rothman KJ. Congenital heart-disease in relation to maternal use of bendectin and other drugs in early-pregnancy. N Engl J Med. 1985 Aug 8;313(6):347-52. doi: 10.1056/NEJM198508083130603
Cann CI, Fried MP, Rothman KJ. Epidemiology of squamous-cell cancer of the head and neck. Otolaryngol Clin N Am. 1985 Aug 1;18(3):367-88.
Hershey N, Cann CI, Rothman KJ. Reply: overcoming hurdles to epidemiologic research. E & HR. 1985 Mar;7(2):9. doi: 10.2307/3564146